Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
DIP is smoking-related interstitial lung disease; smoking cessation (most important), steroids in progressive, supportive care.
呼吸内科Acute interstitial pneumonia (Hamman-Rich) is acute diffuse lung injury; supportive ventilation, steroids in selected, ICU care.
呼吸内科Respiratory bronchiolitis-interstitial lung disease (RB-ILD) (J84.800x006) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological i
Nonspecific interstitial pneumonia (NSIP) (J84.800x005) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is bein
Cryptogenic organizing pneumonia (COP) (J84.800x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being c
Usual interstitial pneumonia (UIP) (J84.800x003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compi
Other specified interstitial lung disease (J84.800) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being co
Pulmonary sclerosis (J84.110) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Post-inflammatory pulmonary fibrosis (J84.109) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compile
Organizing pneumonia (J84.108) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Interstitial fibrosing alveolitis (J84.105) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Idiopathic pulmonary interstitial fibrosis (J84.104) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being c
Hamman-Rich syndrome (J84.103) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Pulmonary granuloma (J84.102) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Pulmonary interstitial fibrosis (J84.101) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
IPF is progressive fibrosing interstitial pneumonia with UIP pattern; antifibrotics (pirfenidone/nintedanib), oxygen, rehab, transplant referral, treat exacerbations.
呼吸内科Diffuse pulmonary interstitial fibrosis (J84.100x008) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being
Secondary pulmonary interstitial fibrosis (J84.100x007) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is bein
Fibrosing alveolitis (J84.100x006) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Other interstitial pulmonary fibrosis (J84.100) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compil
|